Renal Cell Carcinoma Flashcards
Define Renal Cell Carcinoma
Renal malignancy arising from the renal parenchyma/cortex
Accounts for 85% of kidney cancer
Aetiology of Renal Cell Carcinoma
Unknown Genetics: - Von Hippel-Lindau (VHL) (autdom) - Folliculin (FLCN) - Mesenchymal-epithelial transition factor (MET) - Fumarate hydratase (FH) - Succinate dehydrogenase (SDH) - BAP1
Renal cell carcinoma can spread haematogenously (classically to the lungs, leading to ‘cannon ball metastases’), locally (into the renal vein and inferior vena cava for example), and via the lymphatic system.
Renal cell carcinomas often present late on in their course, and up to 30% of patients may have metastases and a poor prognosis by that time.
Risk factors for Renal Cell Carcinoma
Smoking (20-30% in men, 10-20% in women) Male Obesity Hypertension Renal transplantation and end-stage renal disease Age >55 Residence in developed countries Black/american-indian ethnicity \+ve family history of RCC History of hereditary syndromes of acquired renal cystic disease
Epidemiology of Renal Cell carcinoma
• Accounts for 80-90% of all kidney cancers
Median age 64
Symptoms of Renal Cell Carcinoma
Renal carcinoma is often detected incidentally while such investigations are being performed for other conditions.
Macroscopic haematuria Flank pain Systemic symptoms: weight loss, lethargy, fever, sweats, pallor Lower Limb swelling Scrotal Varicoele
Von Hippel Lindau: vision loss
Signs of Renal Cell Carcinoma
Haematuria
Palpable abdominal mass
Lower limb oedema (inferior vena cava involvement)
Scrotal varicocoele
Paraneoplastic presentation:
- Hepatic dysfunction: ascites, hepatomegaly, spider angiomata
- Myoneuropathy
Investigations for Renal Cell Carcinoma
CT abdomen/pelvis: Renal mass, regional lymphadenopathy, and/or visceral/bone metastases
Biopsy: malignancy (not required when imaging
Urinalysis: haematuria and/or proteinuria
FBC: Reduced Hb or elevated RBCs (paraneoplastic)
LDH: raised 1.5x in advanced RCC
Corrected calcium: Raised 2/5x in advanced RCC
LFTs: ?mets/paraneoplastic
Coagulation: prolonged PT (paraneoplastic)
U+Es: Cr elevated
USS: abnormal cyst/mass, lymphadenopathy
MRI: renal mass
CT CAP: staging